Conjoint Associate Professor
Associate Professor Puhong Zhang
Medicine & Health
School of Biomedical Sciences
Puhong Zhang, conjoint associate professor at UNSW and senior researcher at the George Institute for Global Health (TGI) China office, is the Associate Director of TGI China, in charge of Diabetes, Women's & Child Health and Nutrition & Lifestyle programs and the Director of China Center for mHealth Innovation (CCmHI). Dr. Zhang received his doctoral degree on Epidemiology and Statistics in 2004. He has 6 years of teaching and 16 years of experience in disease control and prevention with the focus on non-communicable chronic disease (NCD). He has been responsible for 11 projects, as PI or Co-PI, with total grant of AUD 26M (25M covering the past 3 years). Of the 11 grants, 7 are peer-reviewed funding with total amount of AUD 12.8M. Diabetes, nutrition and mHealth innovation are the major research areas. Over 2-3 years of incubation, 14 SCI papers has been published in the past 3 years and dozens of abstracts have been presented in various scientific conferences. After years of work for and in collaboration with the Ministry of Health and the CDC of China, and other global agencies, Dr Zhang has established good relationship with the key stakeholders both in China and globally.
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
Present
- 2015-2017 Co-PI. Development of clinical pathway of diagnosis and treatment for hospitalized patients comorbid with T2DM and OSA (DOSA2 study). Beijing Science and Technology Bureau (D141107005314005): ￥600K.
- 2015-2018. PI. China Center for mHealth Innovation (CCmHI), a collection of mHealth research program to support people to receive/provide better health services. Qualcomm Wireless Reach: US$1.8M.
- 2016-2018. PI. mHealth platform for maternal and child health care (1000-day Project). CCTF (China Children and Teenagers’ Fund): US$575K.
- 2015-2019. PI-China. Systematic Medical Assessment, Referral and Treatment for Diabetes care in China using Lay Family Health Promoters (SMART Diabetes study). Australia Government NHMRC- Global Alliance for Chronic Diseases (Application ID: APP1094712): AU$1,38M.
- 2016-2021. PI. Project 5 (Smart Diet study) in Development and scale-up of key technologies on nutrition and behavior change for cardiovascular health --- National Key Basic Research Program on Major Chronic Non-communicable Disease in China. MOST (Ministry of Science and Technology of People’s Republic of China; application ID: 2016YFC1300200): ￥1M.
- 2017-2020. Co-PI. Road to hierarchical diabetes management at primary care settings in China (ROADMAP Study). Bethune Charitable Foundation:￥10.1M.
- 2017-2021 Co-PI. NIHR Unit Action on Salt China (ASC). National Institute for Health Research (NIHR) (Project number 16/136/77: NIHR Global Health Research Unit): £6.6M.
Past
- 2004-2006. PI. Surveillance of chronic diseases and risk factors in Beijing adults (2005) (16861 randomized citizens were investigated). Beijing Health Bureau: ￥1,35M.
- 2006-2008. PI. Establishment of Family Health Promotor program in urban area of Beijing. Beijing Health Bureau (118-package-project): ￥750k.
- 2010-2013. PI. Establishment and assessment of a school-student-family interactive healthy diet promotion model. DANONE Foundation (DIC2010-09): ￥200K.
- 2011-2012. Co-PI/PM. Type 1 Diabetes in China: building a comprehensive evidence base of its coverage, cost and care (3C study). International Diabetes Federation (IDF): ￥2.87M.
- 2011-2013. Co-PI/PM. Diabetes and Obstructive Sleep Apnea in China (DOSA 1 study). ResMed Foundation: US$100K.
- 2011-2016. Co-PI/PM. Observational Registry for Basal Insulin Treatment in China (ORBIT study). Sanofi-Aventis (China) Investment Co., Ltd.: ￥37.8M.
- 2014-2015. PI. Efficacy of Telmisartan 40mg and Hydrochlorothiazide 25mg monotherapy in high sodium intake patients with mild to moderate hypertension: a multicenter randomized double-blinded parallel controlled trial (THAT study) . Ministry of Science and Technology of P.R. China (2013 BAI05B02): ￥600K.
Dr. Zhang is leading several research projects with the purpose of improving healthy lifestyles and control of body weight, diabetes and hypertension based on mHealth technologies. His research interests mainly focus on innovative mHealth and diabetes research.